Browse by People

Collapse authors list.
Rossi, Niccolo, Lee, Karla A, Bermudez, Maria V, Visconti, Alessia, Thomas, Andrew Maltez, Bolte, Laura A, Bjork, Johannes R, Ruijter, Laura Kist de, Newton-Bishop, Julia, Harland, Mark et al (show 16 more authors) , Shaw, Heather M, Harries, Mark, Sacco, Joseph, Board, Ruth, Lorigan, Paul, Vries, Elisabeth GE de, Segata, Nicola, Taams, Leonie, Papa, Sophie, Spector, Tim D, Nathan, Paul, Weersma, Rinse K, Hospers, Geke AP, Fehrmann, Rudolf SN, Bataille, Veronique and Falchi, Mario (2022) Circulating inflammatory proteins associate with response to immune checkpoint inhibition therapy in patients with advanced melanoma. EBIOMEDICINE, 83. 104235-.

Collapse authors list.
Carvajal, Richard D, Butler, Marcus O, Shoushtari, Alexander N, Hassel, Jessica C, Ikeguchi, Alexandra, Hernandez-Aya, Leonel, Nathan, Paul, Hamid, Omid, Piulats, Josep M, Rioth, Matthew et al (show 11 more authors) , Johnson, Douglas B, Luke, Jason J, Espinosa, Enrique, Leyvraz, Serge, Collins, Laura, Goodall, Howard M, Ranade, Koustubh, Holland, Chris, Abdullah, Shaad E, Sacco, Joseph J and Sato, Takami (2022) Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial. Nature Medicine, 28 (11). 2364-+.

Collapse authors list.
Nathan, Paul, Hassel, Jessica C, Rutkowski, Piotr, Baurain, Jean-Francois, Butler, Marcus O, Schlaak, Max, Sullivan, Ryan J, Ochsenreither, Sebastian, Dummer, Reinhard, Kirkwood, John M et al (show 18 more authors) , Joshua, Anthony M, Sacco, Joseph J, Shoushtari, Alexander N, Orloff, Marlana, Piulats, Josep M, Milhem, Mohammed, Salama, April KS, Curti, Brendan, Demidov, Lev, Gastaud, Lauris, Mauch, Cornelia, Yushak, Melinda, Carvajal, Richard D, Hamid, Omid, Abdullah, Shaad E, Holland, Chris, Goodall, Howard and Piperno-Neumann, Sophie (2021) Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma. NEW ENGLAND JOURNAL OF MEDICINE, 385 (13). pp. 1196-1206.

Collapse authors list.
Carvajal, Richard D, Nathan, Paul, Sacco, Joseph J, Orloff, Marlana, Hernandez-Aya, Leonel F, Yang, Jessica, Luke, Jason J, Butler, Marcus O, Stanhope, Sarah, Collins, Laura et al (show 4 more authors) , McAlpine, Cheryl, Holland, Chris, Abdullah, Shaad E and Sato, Takami (2022) Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma. Journal of Clinical Oncology, 40 (17). 1939-+.

Collapse authors list.
Cebon, Jonathan S, Gore, Martin, Thompson, John F, Davis, Ian D, McArthur, Grant A, Walpole, Euan, Smithers, Mark, Cerundolo, Vincenzo, Dunbar, P Rod, MacGregor, Duncan et al (show 23 more authors) , Fisher, Cyril, Millward, Michael, Nathan, Paul, Findlay, Michael PN, Hersey, Peter, Evans, TR Jeffry, Ottensmeier, Christian Hermann ORCID: 0000-0003-3619-1657, Marsden, Jeremy, Dalgleish, Angus G, Corrie, Pippa G, Maria, Marples, Brimble, Margaret, Williams, Geoff, Winkler, Sintia, Jackson, Heather M, Endo-Munoz, Liliana, Tutuka, Candani SA, Venhaus, Ralph, Old, Lloyd J, Haack, Dennis, Maraskovsky, Eugene, Behren, Andreas and Chen, Weisan (2020) Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 8 (1). e000410-.

Collapse authors list.
Visconti, Alessia, Rossi, Niccolo, Deris, Helena, Lee, Karla A, Hanic, Maja, Trbojevic-Akmacic, Irena, Thomas, Andrew M, Bolte, Laura A, Bjork, Johannes R, Hooiveld-Noeken, Jahlisa S et al (show 17 more authors) , Board, Ruth, Harland, Mark, Newton-Bishop, Julia, Harries, Mark, Sacco, Joseph J, Lorigan, Paul, Shaw, Heather M, de Vries, Elisabeth GE, Fehrmann, Rudolf SN, Weersma, Rinse K, Spector, Tim D, Nathan, Paul, Hospers, Geke AP, Sasieni, Peter, Bataille, Veronique, Lauc, Gordan and Falchi, Mario (2023) Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma. BMC CANCER, 23 (1). 166-.